Yuhui Chen

Dr. Yuhui Chen


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

28 July 2022 in Brain Sciences
Verified
Journal Article
Open access
PDF file
QWQianwen Wang
Qianwen Wang
YCYuhui Chen
Yuhui Chen
LMLingbing Meng
Lingbing Meng
JYJiawen Yin
Jiawen Yin
LWLi Wang
Li Wang
TGTao Gong
Tao Gong
Ischemic stroke is a life-threatening condition that also frequently results in long-term disability. Currently, intravenous thrombolysis with tissue plasminogen activator and mechanical thrombectomy is the most popular treatment. However, the narrow time window and related complications limit the treatment benefits. Exosomes have recently emerged as ideal therapeutic candidates for ischemic stroke with the ability to pass through the blood_brain barrier and mediate intercellular communication, in addition, exosomes and their contents can be bioengineered to implement targeted delivery. In the last two decades, exosomes and exosomal noncoding RNAs have been found to be involved in the pathophysiological progression of ischemic stroke, including atherosclerosis, apoptosis, inflammation, oxidative stress, and neurovascular remodeling. In this review, we describe the latest progress regarding the role of exosomal long noncoding RNAs and circular RNAs in the occurrence, progression, and recovery of ischemic stroke. Exploration of exosomal noncoding RNAs and their correlated effects in ischemic stroke may facilitate accurate diagnosis, and they may serve as new therapeutic targets for the disease.

22 April 2021 in Journal of Clinical Ultrasound
Verified
Journal Article
Closed access
PDF file
YCYuhui Chen
Yuhui Chen
HXHaiying Xing
Haiying Xing
JWJiexi Wen
Jiexi Wen
QPQing Peng
Qing Peng
RLRan Liu
Ran Liu
YHYining Huang
Yining Huang

22 July 2025 in Journal of Molecular Medicine
Verified
Journal Article
Closed access
PDF file
QWQianwen Wang
Qianwen Wang
LMLingbing Meng
Lingbing Meng
RXRuofan Xu
Ruofan Xu
JYJiawen Yin
Jiawen Yin
DLDeping Liu
Deping Liu
YCYuhui Chen
Yuhui Chen

22 July 2023 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Open access
YCYuhui Chen
Yuhui Chen
FLFang Liu
Fang Liu
JCJuan Chen
Juan Chen
DWDongdong Wu
Dongdong Wu
JHJing He
Jing He
YLYinhong Liu
Yinhong Liu
People with arteriosclerotic cardiovascular diseases (ASCVD) frequently use antithrombotic agents and statins. The objective of the study was to explore the prevalence and risk factors of cerebral microbleeds (CMBs) in elderly (≥ 65 years old) Chinese people with ASCVD. We prospectively included 755 eligible participants with complete MRI data, and CMBs were discerned on the SWI sequence. Multivariate logistic regression was performed to analyze risk factors associated with CMBs. The average age was 74.9 ± 9.5 years, and the prevalence of CMBs was 37.9% (286/755). Of those with CMBs, 65.0% (186/286) had strictly lobar CMBs, 35.0% (100/286) had deep or infratentorial CMBs with or without lobar CMBs. We divided CMBs into two groups according to their locations, lobar CMBs group (strictly lobar CMBs) and deep CMBs group (with or without lobar CMBs). Age per 10 years (odds ratio (OR) 1.42, 95% confidence interval (CI) 1.17-1.72, p < 0.001), statin use (OR 1.54, 95% CI 1.05-2.26, p = 0.03), and lacunes (OR 1.70, 95% CI 1.09-2.68, p = 0.02) were associated with any CMBs. Age per 10 years (OR 1.33, 95% CI 1.10-1.63, p < 0.001), statin use (OR 1.67, 95% CI 1.12-2.50, p = 0.01), and white matter hyperintensities (OR 1.71, 95% CI 1.17-2.51, p < 0.01) were associated with lobar CMBs. Only lacunes were associated with deep CMBs (OR 3.29, 95% CI 1.85-5.87, p < 0.001). In elderly people with risk factors of ASCVD, antithrombotic drug use was not associated with any CMBs, lobar CMBs, or deep CMBs. Statin use was correlated with lobar CMBs but not deep CMBs.

9 June 2025 in Proceedings of the ACM on Interactive, Mobile, Wearable and Ubiquitous Technologies
Verified
Journal Article
Open access
ZWZhi Wang
Zhi Wang
BJBeihong Jin
Beihong Jin
YCYuhui Chen
Yuhui Chen
FZFusang Zhang
Fusang Zhang
SLSiheng Li
Siheng Li
YFYu Fu
Yu Fu
Arterial elasticity is the capability of the arteries to dilate and constrict in response to fluctuations in blood pressure as the heart circulates blood throughout the body, serving as an important indicator for assessing arterial health. However, conventional medical detection methods are often complex, costly, and require direct contact between the user's skin and the device, making them impractical for regular monitoring. In this paper, we propose a contactless single-site arterial elasticity assessment approach using ultra-wideband (UWB) signals, where we estimate the brachial-ankle pulse wave velocity, a key indicator of arterial health, by analyzing the UWB signals reflected off the back of a subject sitting still. Specifically, we first propose preprocessing methods to reduce noise in the received UWB signals, and then design a deep generative adversarial network to generate pulse wave signals from these UWB signals. The generated signals are of high quality and fidelity, exhibiting characteristics of vasoconstriction and vasodilation. Further, we analyze the pulse wave and extract the features related to arterial elasticity from the generated pulse waves. Finally, we employ random forest regression to predict pulse transit time and a body-height based method to estimate the length of the pulse transit path, so as to achieve single-site arterial elasticity assessment. We build the corresponding system named RF-AE and conduct extensive experiments to evaluate its performance. The experimental results show that RF-AE can accurately predict the arterial elasticity of users.